Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.5K
Skin Cancer01:30

Skin Cancer

5.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Metastasis02:30

Metastasis

5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pitfalls in the diagnosis of melanocytic tumours: is immunohistochemistry helpful?

Polish journal of pathology : official journal of the Polish Society of Pathologists·2026
Same author

Immunohistochemistry in the differential diagnosis of cutaneous spindle cell neoplasms.

Polish journal of pathology : official journal of the Polish Society of Pathologists·2026
Same author

S1 guideline sweat gland carcinoma.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

Classification of High- and Low-Risk Patients With Dermal Leiomyosarcoma: An Exploratory Nationwide Cohort Study.

Journal of surgical oncology·2026
Same author

Cutaneous angiosarcoma: Long-term outcomes and risk factors of local recurrence, metastasis and disease-specific mortality in a Danish nationwide cohort.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

[Immunohistochemistry of melanocytic tumours].

Pathologie (Heidelberg, Germany)·2026

Related Experiment Video

Updated: May 4, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

9.9K

Cutaneous mesenchymal tumours: an update.

Thomas Mentzel1

  • 1Dermatopathology Bodensee Friedrichshafen, Germany.

Pathology
|January 1, 2014
PubMed
Summary

This review covers rare skin and subcutaneous mesenchymal tumors, highlighting their diverse features and differences from deeper soft tissue neoplasms. It discusses key variants of dermatofibroma, atypical fibroxanthoma, and dermatofibrosarcoma protuberans, alongside vascular and perivascular neoplasms.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.3K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K

Related Experiment Videos

Last Updated: May 4, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

9.9K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.3K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K

Area of Science:

  • Dermatopathology
  • Surgical Pathology
  • Oncology

Background:

  • Mesenchymal tumors of the skin and subcutis are uncommon and exhibit significant clinicopathological diversity.
  • Superficial mesenchymal neoplasms present distinct clinical, morphological, and prognostic characteristics compared to deeper soft tissue counterparts.

Purpose of the Study:

  • To review clinically important variants of dermatofibroma.
  • To discuss atypical fibroxanthoma and pleomorphic dermal sarcoma.
  • To examine morphologically important variants of dermatofibrosarcoma protuberans, post-radiation vascular lesions, and cutaneous perivascular neoplasms.

Main Methods:

  • Literature review focusing on mesenchymal tumors of the skin and subcutis.
  • Analysis of clinicopathological heterogeneity in superficial neoplasms.
  • Categorization of specific tumor types including variants and associated lesions.

Main Results:

  • Dermatofibromas, atypical fibroxanthomas, and dermatofibrosarcoma protuberans show significant variations.
  • Post-radiation vascular lesions and cutaneous perivascular neoplasms represent distinct entities.
  • Superficial location influences the presentation and prognosis of these mesenchymal tumors.

Conclusions:

  • Understanding the heterogeneity of cutaneous mesenchymal tumors is crucial for accurate diagnosis and management.
  • Distinguishing superficial from deep soft tissue neoplasms aids in appropriate clinical and prognostic assessment.
  • This review provides a comprehensive overview of key superficial mesenchymal tumor entities and their variants.